PRINCETON, NJ – Feb. 14, 2018 – Certara today announced the launch of version 10 of D360, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query diverse cheminformatics and bioinformatics data sources to make informed go/no go research decisions.
Tag: Scientific Informatics
D360 Partner is an affordable add-on product for D360 for external partners that allows for seamless, secure sharing of data and analysis while advancing communication and collaboration.
Certara’s Phoenix Technology Services team helped Arvinas integrate D360 Express with McNeil’s Assay Capture and Analysis System to facilitate structure-activity relationship analysis and save time.
This webinar focused on using D360 to get the most out of drug discovery data by utilizing simple query-building with integrated chemistry tools and analysis tools, dynamically linked data visualizations, and easy to use annotations.
PRINCETON, NJ – Jan. 31, 2017 – Certara today announced that it has released D360 version 9.0 along with D360 Express, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution.
D360 Express is an out-of-the-box integrated solution specifically designed for discovery scientists at smaller pharmaceutical research organizations. It provides access, integration, analysis and visualization of scientific data from multiple data sources. D360 Express gets you up and running quickly and affordably.
Discovery drug research requires understanding complex biological, chemical, logistical and computational data from a wide variety of data sources. Certara’s D360 platform was specifically designed to meet the discovery researcher’s workflow needs.
PRINCETON, NJ – June 23, 2016 – The D360 packaged informatics solution reduces research cycle time, delivering faster insights for busy discovery scientists.
A global top-10 pharma company engaged in an initiative using Certara’s D360 to better address cross-study analysis of pre-clinical safety data.
A small biotech company used Certara’s D360 to better address access and analysis of chemical and biological data by its scientists.